ACM
COLL icon

Altium Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Altium Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-90,000
Closed -$2.09M – 94
2022
Q4 		$2.09M Sell
90,000
-26,000
-22% -$524K 1.06% 34
2022
Q3 		$1.86M Hold
116,000
– – 0.68% 59
2022
Q2 		$2.06M Buy
+116,000
New +$1.95M 0.82% 49

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Altium Capital Management's COLL Position: Q1 2023 in Review

Altium Capital Management sold out of Collegium Pharmaceutical (COLL) in Q1 2023, closing a stake of 90,000 shares — an estimated $2.09M sold.

Altium Capital Management first reported a position in COLL in Q2 2022 and held it in 3 quarters. The position peaked at $2.09M in Q4 2022. 198 funds tracked by Wall St. Rank hold COLL as of Q1 2023.

  • Altium Capital Management reported no remaining Collegium Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Altium Capital Management sold 90,000 Collegium Pharmaceutical shares in Q1 2023, an estimated $2.09M.
  • Altium Capital Management first reported a position in Collegium Pharmaceutical in Q2 2022 and held it in 3 quarters.
  • Altium Capital Management's Collegium Pharmaceutical position peaked at $2.09M in Q4 2022.
  • 198 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2023.

Based on Altium Capital Management's 13F filing for Q1 2023, filed 15 May 2023.